Shares of Medicure Inc. (OTCMKTS:MCUJF – Get Free Report) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.71 and traded as low as $0.53. Medicure shares last traded at $0.53, with a volume of 420 shares changing hands.
Medicure Stock Performance
The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.64 and a current ratio of 2.03. The company has a market cap of $5.55 million, a PE ratio of -3.80 and a beta of 1.00. The business’s 50-day moving average is $0.64 and its 200 day moving average is $0.71.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Further Reading
- Five stocks we like better than Medicure
- What Are Trending Stocks? Trending Stocks Explained
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- What is the Euro STOXX 50 Index?
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- What Are Dividend Champions? How to Invest in the Champions
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png?v=20240611082633&h=45&w=95&zc=2){kind=logo}